Infection of Vero cells by BK virus is dependent on caveolae

Journal of Virology

Volumn 78, Issue 21, 2004, Pages 11583-11590

  Eash, Sylvia ^a,b   Querbes, William ^a,b   Atwood, Walter J ^b  

^a BROWN UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAVEOLIN 1; CHOLERA TOXIN; CHOLESTEROL; CLATHRIN; PROTEIN TYROSINE KINASE; TRANSFERRIN;

ANIMAL CELL; ARTICLE; BK VIRUS; CAVEOLA; CELL PH; CONTROLLED STUDY; ENDOCYTOSIS; ENDOSOME; ENZYME INHIBITION; NONHUMAN; PRIORITY JOURNAL; VERO CELL; VIRUS INFECTION;

ANIMALS; BK VIRUS; CAVEOLAE; CERCOPITHECUS AETHIOPS; CHLOROQUINE; CHOLESTEROL; ENDOCYTOSIS; HYDROGEN-ION CONCENTRATION; VERO CELLS;

EID: 6344219974     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.21.11583-11590.2004     Document Type: Article

References (65)

1. Agha, I. A., and D. C. Brennan. 2002. BK virus and current immunosuppressive therapy. Graft 5:S65-S72.
2. Anderson, H. A., Y. Chen, and L. C. Norkin. 1996. Bound Simian Virus 40 translocates to caveolin enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae. Mol. Biol. Cell 7:1825-1834.
3. Ashok, A., and W. J. Atwood. 2003. Contrasting roles of endosomal pH and the cytoskeleton in infection of human glial cells by JC virus and simian virus 40. J. Virol. 77:1347-1356.
4. Bender, F., M. Montoya, V. Monardes, L. Leyton, and A. Quest. 2002. Caveolae and caveolae-like membrane domains in cellular signaling and disease: identification of downstream targets for the tumor suppressor protein caveolin-1. Biol. Res. 35:139-150.
5. Benmerah, A., C. Lamaze, B. Begue, S. L. Schmid, A. Dautry-Varsat, and N. Cerf-Bensussan. 1998. AP-2/Eps15 interaction is required for receptor-mediated endocytosis. J. Cell Biol. 140:1055-1062.
6. Benmerah, A., V. Poupon, N. Cerf-Bensussan, and A. Dautry-Varsat. 2000. Mapping of Eps15 domains involved in its targeting to clathrin-coated pits. J. Biol. Chem. 275:3288-3295.
7. Brown, D. A., and E. London. 1997. Structure of detergent-resistant membrane domains: does phase separation occur in biological membranes? Biochem. Biophys. Res. Commun. 240:1-7.
8. Carbone, R., S. Fre, G. Iannolo, F. Belleudi, P. Mancini, P. G. Pelicci, M. R. Torrisi, and P. P. Difiore. 1997. eps1S and eps15R are essential components of the endocytic pathway. Cancer Res. 57:5498-5504.
9. Chen, Y., and L. C. Norkin. 1999. Extracellular Simian Virus 40 transmits a signal that promotes virus enclosure within caveolae. Exp. Cell Res. 246:83-90.
10. di Tarante, C., V. Pietropaulo, G. B. Orsi, L. Jin, L. Sinibaldi, and A. M. Degener. 1997. Detection of BK polyomavirus genotypes in healthy and HIV-positive children. Eur. J. Epidemiol. 13:653-657.
11. Dorries, K., and C. Elsner. 1991. Persistent polyomavirus infection in kidney tissue of patients with disease other then progressive multifocal leucoencephalopathy. Virol. Adv. 10:51-61.
12. Drachenberg, C. B., J. C. Papadimitriou, R. Wali, C. Cubitt, and E. Ramos. 2003. BK polyoma virus allograft nephropathy: ultrastructural features from viral cell entry to lysis. Am. J. Transplant. 3:1383-1392.
13. Fishman, J. A. 2002. BK virus nephropathy-polyomavirus adding insult to injury. N. Engl. J. Med. 347:527-530.
14. Fishman, P. H. 1982. Internalization and degradation of cholera toxin by cultured cells: relationship to toxin action. J. Cell Biol. 93:860-865.
15. Gilbert, J. M., and T. L. Benjamin. 2000. Early steps of polyomavirus entry into cells. J. Virol. 74:8582-8588.
16. Gilbert, J. M., I. G. Goldberg, and T. L. Benjamin. 2003. Cell penetration and trafficking of polyomavirus. J. Virol. 77:2615-2622.
17. Harlow, E., and D. Lane. 1988. Antibodies; a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
18. Howley, P. M. (ed.). 1980 Viral oncology. Raven Press, New York, N.Y.
19. Jin, L., J. Park, S. Lee, B. Park, S. J., K. Song, T. Ahn, S. Hwang, B. Ahn, and K. Ahn. 2002. Hantaan virus enters cells by clathrin-dependent receptor-mediated endocytosis. Virology 294:60-69.
20. Kahan, A. V., D. V. Coleman, and L. G. Koss. 1980. Activation of human polyomavirus infection-detection by cytologic techniques. Am. J. Clin. Pathol. 74:326-332.
21. Khalili, K., and G. L. Stoner (ed.). 2001. Human polyomaviruses. Wiley-Liss, Inc., New York, N.Y.
22. Knipe, D. M., and P. M. Howley (ed.). 2001 Fundamental virology, 4th ed. Lippincott Williams & Wilkins, Philadelphia, Pa.
23. Koss, L. G. (ed.). 1992. Diagnostic cytology and its histopathologic basis, 4th ed., vol. 2. Lippincott, Philadelphia, Pa.
24. Le, P., and I. R. Nabi. 2003. Distinct caveolae-mediated endocytic pathways target the Golgi apparatus and the endoplasmic reticulum. J. Cell Sci. 116: 1059-1071.
25. Machleidt, T., W. P. Li, P. Liu, and R. G. W. Andersen. 2000. Multiple domains in caveolin-1 control its intracellular traffic. J. Cell Biol. 148:17-28.
26. Mantyjarvi, R., H. Karjalainen, and M. Laaksonen. 1984. Cell-mediated immune reaction against BK virus-transformed cells. Cancer Immunol. Immunother. 17:28-32.
27. Mantyjarvi, R., O. Meumiam, L. Vihma, and B. Berglund. 1973. Human papovavirus (B.K.), biological properties and seroepidemiology. Ann. Dis. Res. 5:283-287.
28. Marsh, M., and A. Helenius. 1989. Virus entry into animal cells. Adv. Virus Res. 36:107-151.
29. Nabi, I. R., and P. U. Le. 2003. Caveolae/raft-dependent endocytosis. J. Cell Biol. 161:673-677.
30. Narayan, S., R. Barnard, and J. Young. 2003. Two retroviral entry pathways distinguished by lipid raft association of the viral receptors and differences in viral infectivity. J. Virol. 77:1977-1983.
31. Nichols, B. J. 2002. A distinct class of endosome mediates clathrin-independent endocytosis to the Golgi complex. Nat. Cell Biol. 4:374-378.
32. Nichols, B. J., A. K. Kenworthy, R. S. Polishchuk, R. Lodge, T. Roberts, K. Hirschberg, R. D. Phair, and J. Lippincott-Schwartz. 2001. Rapid recycling of lipid raft markers between the cell surface and Golgi complex. J. Cell Biol. 153:529-541.
33. Nickeleit, V., H. H. Hirsch, I. F. Binet, F. Gudat, O. Prince, and P. Dalquen. 1999. Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. J. Am. Soc. Nephrol. 10:1080-1089.
34. Nickeleit, V., J. Steiger, and M. J. Mihatsch. 2002. BK virus infection after kidney transplantation. Graft Organ Cell Transplant. 5:S46-S57.
35. Nystrom, F. H., E. Chen, L. Cong, Y. Li, and M. Quon. 1999. Caveolin-1 interacts with the insulin receptor and can differentially modulate insulin signaling in transfected Cos-7 cells and rat adipose cells. Mol. Endocrinol. 13:2013-2024.
36. Padgett, B. L., and D. L. Walker. 1973. Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. J. Infect. Dis. 127:467-470.
37. Parten, R. G. 1994. Ultrastructural localization of gangliosides; GM1 is concentrated in caveolae. J. Histochem. Cytochem. 42:155-166.
38. Pelkmans, L., and A. Helenius. 2002. Endocytosis via caveolae. Traffic 3:311-320.
39. Pelkmans, L., and A. Helenius. 2003. Insider information: what viruses tell us about endocytosis. Curr. Opin. Cell Biol. 15:414-422.
40. Pelkmans, L., J. Kartenbeck, and A. Helenius. 2001. Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat. Cell Biol. 3:473-483.
41. Pelkmans, L., D. Puntener, and A. Helenius. 2002. Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science 296:535-539.
42. Petrogiannis-Haliotis, T., G. Sakoulas, J. Kirby, I. J. Koralnik, A. M. Dvorak, R. Monahan-Earley, U. De Girolami, M. Upton, E. O. Major, L.-A. Poster, and J. T. Joseph. 2001. BK-related polyomavirus vasculopathy in a renal-transplant recipient. N. Engl. J. Med. 345:1250-1255.
43. Pho, M. T., A. Ashok, and W. J. Atwood. 2000. JC virus enters human glial cells by clathrin dependent receptor mediated endocytosis. J. Virol. 74:2288-2292.
44. Querbes, W., A. Benmerah, D. Tosoni, P. P. Di Fiore, and W. J. Atwood. 2004. A JC virus-induced signal is required for infection of glial cells by a clathrin- and eps15-dependent pathway. J. Virol. 78:250-256.
45. Raptis, L. (ed.). 2001. SV40 protocols, vol. 165. Humana Press Inc., Totowa, N.J.
46. Razani, B., A. Schlegel, J. Liu, and M. P. Lisanti. 2001. Caveolin-1, a putative tumor suppressor gene. Biochem. Soc. Trans. 29:494-499.
47. Richterova, Z., D. Liebl, M. Horak, Z. Palkova, J. Stokrova, P. Hozak, J. Korb, and J. Forstova. 2001. Caveolae are involved in the trafficking of mouse polyomavirus virions and artificial VP1 pseudocapsids toward cell nuclei. J. Virol. 75:10880-10891.
48. Roskopf, J., W. Fitzsimmons, N. Ahsan, and D. Laskow. 2002. The pharmacologic treatment of human polyomavirus infection. Graft Organ Cell Transplant. 5:S88-S97.
49. Rothberg, K. G., J. E. Heuser, W. C. Donzell, Y. Ying, J. R. Glenney, and R. G. W. Andersen. 1992. Caveolin, a protein component of membrane coats. Cell 68:673-682.
50. Rothenberger, S., B. J. Iacopetta, and L. C. Kuhn. 1998. Endocytosis of the transferrin receptor requires the cytoplasmic domain but not its phosphorylation site. Cell 49:423-431.
51. Roy, S., R. Luetterforst, A. Harding, A. Apolloni, M. Etheridge, E. Stang, B. Rolls, J. Hancock, and R. G. Parton. 1999. Dominant-negative caveolin inhibits H-Ras function by disrupting cholesterol-rich plasma membrane domains. Nat. Cell Biol. 1:98-105.
52. Schapiro, F., C. Lingwood, W. Furuya, and S. Grinstein. 1998. pH-dependent retrograde targeting of glycolipids to the Golgi complex. Am. J. Physiol. 27:C319-C332.
53. Schlegel, A., V. D. Engelman, J. A. Galbiati, F. Mehta, P. Zhang, X. L. Scherer, and P. E. Lisanti. 1998. Crowded little caves: structure and function of caveolae. Cell Signal 10:457-463.
54. Seganti, L., P. Mastromarino, F. Superti, L. Sinibaldi, and N. Orsi. 1981. Receptors for BK virus on human erythrocytes. Acta Virol. 25:177-181.
55. Shah, K. V. 1996. Polyomaviruses, p. 2027-2043. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Virology. Lippincott-Raven, Philadelphia. Pa.
56. Shinohara, T., M. Matsuda, S. H. Cheng, J. Marshall, M. Fujita, and K. Nagashima. 1993. BK virus infection of the human urinary tract. J. Med. Virol. 41:301-305.
57. Sieczkarski, S. B., and G. R. Whittaker. 2002. Influenza virus can enter and infect cells in the absence of clathrin-mediated endocytosis. J. Virol. 76: 10455-10464.
58. Singh, R. D., V. Puri, J. T. Valiyaveettil, D. L. Marks, R. Bittman, and R. Pagano. 2003, Selective caveolin-1-dependent endocytosis of glycosphingolipids. Mol. Biol. Cell 14:3254-3265.
59. Sinibaldi, L., P. Goldoni, V. Pietropaulo, C. Longhi, and N. Orsi. 1990. Involvement of gangliosides in the interaction between BK virus and Vero cells. Arch. Virol. 113:291-296.
60. Sinibaldi, L., D. Viti, P. Goldoni, G. Cavallo, C. Caroni, and N. Orsi. 1987. Inhibition of BK virus haemagglutination by gangliosides. J. Gen. Virol. 68:879-883.
61. Smart, E. J., G. A. Graf, A. McNiven, W. C. Sessa, J. A. Engelman, P. E. Scherer, T. Okamoto, and M. P. Lisanti. 1999. Caveolins, liquid-ordered domains, and signal transduction. Mol. Cell. Biol. 19:7289-7304.
62. Sundsfjord, A., T. Flaegstad, R. Flo, A. R. Spein, M. Pedersen, and H. Permin. 1994. BK and JC viruses in human immunodeficiency virus type 1-infected persons: prevalence, excretion, viremia, and regulatory regions. J. Infect. Dis. 169:485-490.
63. Toomre, D., and K. Simons. 2000. Lipid rafts and signal transduction. Mol. Biol. Cell 1:31-41.
64. Tran, D., J. L. Carpentier, F. Sawano, P. Gorden, and L. Orci. 1987. Ligands internalized through coated and noncoated invaginations follow a common intracellular pathway. Proc. Natl. Acad. Sci. USA 84:7957-7961.
65. White, J., K. Matlin, and A. Helenius. 1981. Cell fusion by Semliki Forest, influenza and vesicular stomatitis viruses. J. Cell Biol. 89:674-679.